Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Palo Alto, California. The company went IPO on 2022-04-07. The firm's lead program, SP-102, is non-opioid gel formulation administered epidurally in development for patients with moderate to severe chronic radicular pain/sciatica. The company is developing SP-102 to address problems associated with corticosteroid products that are used in practice but not approved for epidural injection or the treatment of sciatica. SP-102 is a Phase III sterile dexamethasone sodium phosphate viscous gel formulation of 10 mg dexamethasone at a 5 mg/mL concentration in a pre-filled glass syringe for delivery via an epidural injection. SP-102 allows for use of potent dexamethasone and provides for longer residency time at the site of injection through the use of a viscous excipient in lieu of particulates. The product is formulated without the use of preservatives and packaged in a pre-filled syringe.
SMNR stock price ended at $5 on Tuesday, after dropping 37.50%
On the latest trading day Apr 21, 2026, the stock price of SMNR fell by 37.50%, dropping from $5.00 to $5.00. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $5.00 and a high of $5.00. On the latest trading day, the trading volume for SMNR decreased by 62 shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 148 shares were traded, with a market value of approximately $1.1B.
SMNR Technical Signals
Technical Signals Summary
Buy Signals 4
Neutral Signals 0
Sell Signals 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
SMNR currently exhibits 4 buy signals and 3 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -37.5% during this period. Overall, the technical indicators point to a Buy outlook for the mid-term.
Bullish/Bearish Signals for SMNR
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for SMNR. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to SMNR?
According to technical analysis, Semnur Pharmaceuticals Inc has an aggregate signal of Buy. Semnur Pharmaceuticals Inc has 4 Buy signals, 0 Neutral Signals and 3 sell signals.
What are the Fibonacci retracement levels for SMNR?
The Fibonacci retracement level for Semnur Pharmaceuticals Inc is above the 0% level
What is the RSI for Semnur Pharmaceuticals Inc?
The RSI for Semnur Pharmaceuticals Inc is currently 23.55, indicating a oversold condition
What is Semnur Pharmaceuticals Inc price for the next 12 months?
Semnur Pharmaceuticals Inc SMNR price for the next 12 months is estimated at $0.
How high is Semnur Pharmaceuticals Inc expected to go?
According to wall street analysts, Semnur Pharmaceuticals Inc is expected to reach a high forecast of $0.